Sjogren's Syndrome Pipeline and Clinical Trials Assessment: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Novartis, Johnson & Johnson, Dompe Farmaceutici, Sylentis, MorphoSys, Resolve Therapeutics, OSE Immunotherapeutics, Horizon T

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sjogren's Syndrome pipeline constitutes 20+ key companies continuously working towards developing 25+ Sjogren's Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Sjogren's Syndrome Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sjogren's Syndrome Market.

The Sjogren's Syndrome Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Sjogren's Syndrome Pipeline Report: https://www.delveinsight.com/sample-request/sjogrens-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Sjogren's Syndrome treatment therapies with a considerable amount of success over the years.
• Sjogren's Syndrome companies working in the treatment market are Rise Therapeutics, Bristol-Myers Squibb, Resolve Therapeutics, Novartis, Horizon Therapeutics, Dompe Farmaceutici, Horizon Therapeutics (Amgen), Sylentis, OSE Immunotherapeutics, Servier, Johnson & Johnson, and others, are developing therapies for the Sjogren's Syndrome treatment
• Emerging Sjogren's Syndrome therapies in the different phases of clinical trials are- R-2487, BMS-986325, RSLV-132, CFZ533, VIB4920, VAY736, Dazodalibep (VIB4920), OXERVATE (cenegermin), Tivanisiran (SYL1001), Lusvertikimab (formerly OSE-127), Nipocalimab, and others are expected to have a significant impact on the Sjogren's Syndrome market in the coming years.
• In November 2023, Amgen released updated findings from its Phase II trial assessing dazodalibep, an experimental medication, in the management of Sjogren's syndrome. According to the data, patients who switched from placebo to dazodalibep demonstrated an enhancement in their disease activity, showing a reduction in the total ESSDAI score from 4.1 points on Day 169 to 6.3 points on Day 365. The overall safety profile of dazodalibep appeared favorable, with the medication being well-tolerated.
• In July 2022, Novartis has commenced a Phase III clinical trial named NEPTUNUS-1, which is a randomized, double-blind, placebo-controlled, 2-arm multicenter study. The primary focus of this trial is to investigate the effectiveness and safety of Ianalumab in individuals with active Sjogren's syndrome. The main outcome parameter for the study is the assessment of changes from baseline in the EULAR Sjögren Syndrome Disease Activity Index (ESSDAI) score at Week 48, in comparison to a placebo.

Sjogren's Syndrome Overview
Sjögren's syndrome is a chronic autoimmune disorder that primarily affects the glands that produce saliva and tears. In this syndrome, the immune system mistakenly attacks and damages the glands, leading to a reduction in the production of saliva and tears. While it most commonly affects the salivary and lacrimal (tear) glands, it can also impact other organs and systems in the body.

Get a Free Sample PDF Report to know more about Sjogren's Syndrome Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/sjogrens-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Sjogren's Syndrome Drugs Under Different Phases of Clinical Development Include:
• R-2487: Rise Therapeutics
• BMS-986325: Bristol-Myers Squibb
• RSLV-132: Resolve Therapeutics
• CFZ533: Novartis
• VIB4920: Horizon Therapeutics
• VAY736: Novartis
• Dazodalibep (VIB4920): Horizon Therapeutics (Amgen)
• OXERVATE (cenegermin): Dompe Farmaceutici
• Tivanisiran (SYL1001): Sylentis
• Lusvertikimab (formerly OSE-127): OSE Immunotherapeutics/Servier
• Nipocalimab: Johnson & Johnson

Sjogren's Syndrome Route of Administration
Sjogren's Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Sjogren's Syndrome Molecule Type
Sjogren's Syndrome Products have been categorized under various Molecule types, such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Sjogren's Syndrome Pipeline Therapeutics Assessment
• Sjogren's Syndrome Assessment by Product Type
• Sjogren's Syndrome By Stage and Product Type
• Sjogren's Syndrome Assessment by Route of Administration
• Sjogren's Syndrome By Stage and Route of Administration
• Sjogren's Syndrome Assessment by Molecule Type
• Sjogren's Syndrome by Stage and Molecule Type

DelveInsight's Sjogren's Syndrome Report covers around 25+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Sjogren's Syndrome product details are provided in the report. Download the Sjogren's Syndrome pipeline report to learn more about the emerging Sjogren's Syndrome therapies at:
https://www.delveinsight.com/sample-request/sjogrens-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Sjogren's Syndrome Therapeutics Market include:
Key companies developing therapies for Sjogren's Syndrome are - Novartis, Johnson & Johnson, Dompe Farmaceutici, Sylentis, MorphoSys, Resolve Therapeutics, OSE Immunotherapeutics, Horizon Therapeutics (Amgen), Servier, and others.

Sjogren's Syndrome Pipeline Analysis:
The Sjogren's Syndrome pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Sjogren's Syndrome with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Sjogren's Syndrome Treatment.
• Sjogren's Syndrome key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Sjogren's Syndrome Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Sjogren's Syndrome market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Sjogren's Syndrome drugs and therapies-
https://www.delveinsight.com/sample-request/sjogrens-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Sjogren's Syndrome Pipeline Market Drivers
• Increasing Prevalence, development of better Classification Criteria, increased research and development are some of the important factors that are fueling the Sjogren's Syndrome Market.

Sjogren's Syndrome Pipeline Market Barriers
• However, lack of specific therapeutic approaches, limited translation of Therapies into the real world and other factors are creating obstacles in the Sjogren's Syndrome Market growth.

Scope of Sjogren's Syndrome Pipeline Drug Insight
• Coverage: Global
• Key Sjogren's Syndrome Companies: Rise Therapeutics, Bristol-Myers Squibb, Resolve Therapeutics, Novartis, Horizon Therapeutics, Dompe Farmaceutici, Horizon Therapeutics (Amgen), Sylentis, OSE Immunotherapeutics, Servier, Johnson & Johnson, and others
• Key Sjogren's Syndrome Therapies: R-2487, BMS-986325, RSLV-132, CFZ533, VIB4920, VAY736, Dazodalibep (VIB4920), OXERVATE (cenegermin), Tivanisiran (SYL1001), Lusvertikimab (formerly OSE-127), Nipocalimab, and others
• Sjogren's Syndrome Therapeutic Assessment: Sjogren's Syndrome current marketed and Sjogren's Syndrome emerging therapies
• Sjogren's Syndrome Market Dynamics: Sjogren's Syndrome market drivers and Sjogren's Syndrome market barriers

Request for Sample PDF Report for Sjogren's Syndrome Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/sjogrens-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Sjogren's Syndrome Report Introduction
2. Sjogren's Syndrome Executive Summary
3. Sjogren's Syndrome Overview
4. Sjogren's Syndrome- Analytical Perspective In-depth Commercial Assessment
5. Sjogren's Syndrome Pipeline Therapeutics
6. Sjogren's Syndrome Late Stage Products (Phase II/III)
7. Sjogren's Syndrome Mid Stage Products (Phase II)
8. Sjogren's Syndrome Early Stage Products (Phase I)
9. Sjogren's Syndrome Preclinical Stage Products
10. Sjogren's Syndrome Therapeutics Assessment
11. Sjogren's Syndrome Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Sjogren's Syndrome Key Companies
14. Sjogren's Syndrome Key Products
15. Sjogren's Syndrome Unmet Needs
16 . Sjogren's Syndrome Market Drivers and Barriers
17. Sjogren's Syndrome Future Perspectives and Conclusion
18. Sjogren's Syndrome Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Sjogren's Syndrome Market https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Sjogren's Syndrome Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Sjogren's Syndrome Epidemiology https://www.delveinsight.com/report-store/sjogrens-syndrome-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Sjogren's Syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.